GC Pharm to develop next-gen premium vaccine in U.S.
GC Pharm will develop a next-generation premium vaccine in the U.S.
GC Pharm(CEO Eun-Cheol Huh) announced on the 21st that the company would found a new company called ‘CUREVO’ in Seattle, Washington and start to develop the next-generation vaccine.
The newly founded CUREVO is planning to condu...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
